PHASE 2 STUDY

Clinical trials for PHASE 2 STUDY explained in plain language.

Never miss a new study

Get alerted when new PHASE 2 STUDY trials appear

Sign up with your email to follow new studies for PHASE 2 STUDY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 2 Not yet finished but already full! 1

New drug trial targets aggressive pancreatic Cancer's genetic weakness

Disease control Terminated

This study is testing if adding an experimental drug called BMS-986504 to standard chemotherapy helps control pancreatic cancer in people whose tumors have a specific genetic change called an MTAP deletion. It aims to see if the combination is safe and can slow cancer growth or i…

Matched conditions: PHASE 2 STUDY

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

PHASE 2 STUDY

Get alerted when new PHASE 2 STUDY trials appear

New drug trial targets aggressive pancreatic Cancer's genetic weakness